CARGO Retained Earnings from 2010 to 2024

CRGX Stock   16.42  0.19  1.17%   
CARGO Therapeutics, Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that CARGO Therapeutics, Common retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals
 
Retained Earnings  
First Reported
2010-12-31
Previous Quarter
-145.1 M
Current Value
-137.9 M
Quarterly Volatility
47.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CARGO Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CARGO Therapeutics,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 2.4 M or Selling General Administrative of 22 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.47. CARGO financial statements analysis is a perfect complement when working with CARGO Therapeutics, Valuation or Volatility modules.
  
Check out the analysis of CARGO Therapeutics, Correlation against competitors.

Latest CARGO Therapeutics,'s Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of CARGO Therapeutics, Common over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. CARGO Therapeutics,'s Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CARGO Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (145.15 M)10 Years Trend
Slightly volatile
   Retained Earnings   
       Timeline  

CARGO Retained Earnings Regression Statistics

Arithmetic Mean(26,840,647)
Coefficient Of Variation(177.91)
Mean Deviation33,268,235
Median(6,048,000)
Standard Deviation47,750,988
Sample Variance2280.2T
Range139.1M
R-Value(0.66)
Mean Square Error1397.8T
R-Squared0.43
Significance0.01
Slope(7,007,957)
Total Sum of Squares31922.2T

CARGO Retained Earnings History

2024-137.9 M
2023-145.1 M
2022-47 M

About CARGO Therapeutics, Financial Statements

CARGO Therapeutics, investors use historical fundamental indicators, such as CARGO Therapeutics,'s Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CARGO Therapeutics,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Retained Earnings-145.1 M-137.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CARGO Stock Analysis

When running CARGO Therapeutics,'s price analysis, check to measure CARGO Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARGO Therapeutics, is operating at the current time. Most of CARGO Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of CARGO Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARGO Therapeutics,'s price. Additionally, you may evaluate how the addition of CARGO Therapeutics, to your portfolios can decrease your overall portfolio volatility.